These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 958506)

  • 1. Pharmacokinetics of phenprocoumon in man investigated using a gas chromatographic method of drug analysis.
    Heni N; Glogner P
    Naunyn Schmiedebergs Arch Pharmacol; 1976 May; 293(2):183-6. PubMed ID: 958506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Elimination kinetics of phenprocoumon (Marcumar) in liver cirrhosis and after premedication with phenobarbital].
    Heni N; Lehnhardt G; Glogner P
    Int J Clin Pharmacol Biopharm; 1976 Jun; 13(4):253-61. PubMed ID: 965132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biotransformation of phenprocoumon in the rat.
    Pohl LR; Haddock RE; Trager WF
    J Med Chem; 1975 May; 18(5):519-23. PubMed ID: 1151963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proceedings: Determination of phenprocoumon (Marcumar R) by gas-liquid-chromatography.
    Schüppel RV; König R; Steinhilber E; Deckert FW
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R87. PubMed ID: 4276643
    [No Abstract]   [Full Text] [Related]  

  • 5. Interaction between phenprocoumon and phytomenadion: a pharmacokinetic investigation in healthy volunteers.
    Haustein KO
    Biomed Biochim Acta; 1984; 43(12):1417-24. PubMed ID: 6534380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of liver cirrhosis on the pharmacokinetics of phenprocoumon.
    Kitteringham NR; Büstgens L; Brundert E; Mineshita S; Ohnhaus EE
    Eur J Clin Pharmacol; 1984; 26(1):65-70. PubMed ID: 6714293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A specific and sensitive method for the determination of the anticoagulant phenprocoumon in plasma.
    Haefelfinger P
    J Chromatogr; 1979 Feb; 162(2):215-22. PubMed ID: 762222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic fate of phenprocoumon in humans.
    Toon S; Heimark LD; Trager WF; O'Reilly RA
    J Pharm Sci; 1985 Oct; 74(10):1037-40. PubMed ID: 4078699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The treatment basis for anticoagulants in horses].
    Sinn D; Wintzer HJ
    Tierarztl Prax; 1990 Oct; 18(5):507-11. PubMed ID: 2264055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of phenprocoumon.
    Haustein KO; Hüller G
    Int J Clin Pharmacol Ther; 1994 Apr; 32(4):192-7. PubMed ID: 8032579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of sulfinpyrazone on the disposition of pseudoracemic phenprocoumon in humans.
    Heimark LD; Toon S; Gibaldi M; Trager WF; O'Reilly RA; Goulart DA
    Clin Pharmacol Ther; 1987 Sep; 42(3):312-9. PubMed ID: 3621786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The reciprocal actions of phenprocoumon (Marcumar) with human serum albumin, erythrocytes and blood].
    Niedner R; von Oettingen U; Meyer F
    Int J Clin Pharmacol Biopharm; 1975 Dec; 12(4):446-57. PubMed ID: 1205658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Separation of the enantiomers of phenprocoumon and warfarin by high-performance liquid chromatography using a chiral stationary phase. Determination of the enantiomeric ratio of phenprocoumon in human plasma and urine.
    de Vries JX; Völker U
    J Chromatogr; 1989 Aug; 493(1):149-56. PubMed ID: 2778004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Observations in phenprocoumon (Marcumar) poisoning. Elimination and serum binding of the anticoagulant atatoxic blood concentration].
    Held H; von Busse G; Meissner J
    Dtsch Med Wochenschr; 1980 Jun; 105(24):860-3. PubMed ID: 7418621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of wheat bran on the pharmacokinetics of phenprocoumon in normal volunteers.
    Kitteringham NR; Mineshita S; Ohnhaus EE
    Klin Wochenschr; 1985 Jun; 63(12):537-9. PubMed ID: 2993733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of frusemide and probenecid on the pharmacokinetics of phenprocoumon.
    Mönig H; Böhm M; Ohnhaus EE; Kirch W
    Eur J Clin Pharmacol; 1990; 39(3):261-5. PubMed ID: 2257863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereoselective drug distribution and anticoagulant potency of the enantiomers of phenprocoumon in rats.
    Schmidt W; Jähnchen E
    J Pharm Pharmacol; 1977 May; 29(5):266-71. PubMed ID: 17688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of phenprocoumon metabolites in human urine by high-performance liquid chromatography and gas chromatography-mass spectrometry.
    De Vries JX; Simon M; Zimmermann R; Harenberg J
    J Chromatogr; 1985 Mar; 338(2):325-34. PubMed ID: 3998021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interruption of the enterohepatic circulation of phenprocoumon by cholestyramine.
    Meinertz T; Gilfrich HJ; Groth U; Jonen HG; Jähnchen E
    Clin Pharmacol Ther; 1977 Jun; 21(6):731-5. PubMed ID: 862312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of coumarin and its 7-hydroxy-metabolites upon intravenous and peroral administration of coumarin in man.
    Ritschel WA; Brady ME; Tan HS; Hoffmann KA; Yiu IM; Grummich KW
    Eur J Clin Pharmacol; 1977 Dec; 12(6):457-61. PubMed ID: 598421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.